Page last updated: 2024-12-08
paratose
Description
paratose: RN given refers to (D-ribo)-isomer; see also record for colitose & tyvelose [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
D-paratose : A paratose that has D-configuration. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
paratose : A dideoxyhexose that is allose in which the hydroxy groups at positions 3 and 6 have been replaced by hydrogens. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
ID Source | ID |
PubMed CID | 12303783 |
CHEBI ID | 63336 |
CHEBI ID | 63335 |
SCHEMBL ID | 22749079 |
MeSH ID | M0079511 |
Synonyms (20)
Synonym |
PAR , |
d-paratose |
paratose |
3,6-dideoxy-d-glucopyranose |
KYPWIZMAJMNPMJ-IANNHFEVSA-N |
paratosylalcohol |
3,6-dideoxy-d-ribo-hexopyranose |
3,6-dideoxy-d-ribose |
3,6-dideoxy-ribo-hexopyranose |
3,6-dideoxy-ribopyranose |
3,6-dideoxy-d-ribopyranose |
3,6-dideoxy-d-ribopyranoside |
3,6-dideoxy-ribose |
d-par |
3,6-dideoxy-ribopyranoside |
C21055 |
SCHEMBL22749079 |
chebi:63336 |
dtxcid20127622 |
chebi:63335 |
Research
Studies (8)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 2 (25.00) | 18.7374 |
1990's | 4 (50.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (12.50%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (87.50%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |